Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis
Amyloid light chain (AL) amyloidosis is a rare disease with poor prognosis and limited therapeutic alternatives. Recently, one clinical case with cardiac involvement, as well as a compelling evidence of green tea polyphenol, epigallocatechin-3-gallate (EGCG), inducing the formation of benign aggrega...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
10 March 2010
|
| In: |
Clinical research in cardiology
Year: 2010, Volume: 99, Issue: 8, Pages: 483-490 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-010-0142-x |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-010-0142-x
|
| Author Notes: | Derliz Mereles, Sebastian J. Buss, Stefan E. Hardt, Werner Hunstein, Hugo A. Katus |
| Summary: | Amyloid light chain (AL) amyloidosis is a rare disease with poor prognosis and limited therapeutic alternatives. Recently, one clinical case with cardiac involvement, as well as a compelling evidence of green tea polyphenol, epigallocatechin-3-gallate (EGCG), inducing the formation of benign aggregation products that do not polymerize into fibrils were published. This is a report of the cardiac effects of green tea consumption in these patients. |
|---|---|
| Item Description: | Gesehen am 19.04.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-010-0142-x |